The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Biomarkers of intestinal wall damage in multiple organ dysfunction syndrome
Journal: Russian Journal of Anesthesiology and Reanimatology. 2024;(2): 114‑120
Views: 526
Downloaded: 3
To cite this article:
Turgunov YeM, Ogizbayeva AV, Mugazov MM, Asamidanova SG. Biomarkers of intestinal wall damage in multiple organ dysfunction syndrome. Russian Journal of Anesthesiology and Reanimatology.
2024;(2):114‑120. (In Russ.)
https://doi.org/10.17116/anaesthesiology2024021114
Increased intestinal wall permeability and impaired barrier function in ICU patients are due to microcirculation disorders, ischemia and hypoxia of intestinal wall. As a result, bacteria and/or their endotoxins penetrate the damaged intestinal wall, enhance immune response and can lead to systemic inflammation, multiple organ dysfunction syndrome, sepsis and even death. This review is devoted to mechanisms of intestinal barrier disruption and the most effective serum biomarkers of intestinal wall damage: zonulin, intestinal fatty acid binding protein (I-FABP) and regenerating islet-derived 3-alpha (REG3α), citrulline. Despite various study limitations, these biomarkers are interesting candidates for identifying patients with high risk of complications and screening for timely intensive care measures. These approaches can reduce ICU-stay and mortality.
Keywords:
Authors:
Received:
03.11.2023
Accepted:
12.12.2023
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.